Labcorp Holdings Inc. LH
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Labcorp Holdings Inc. (LH) EV/Sales
As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a EV/Sales of 2.2×. Over the past ten years it has ranged from 1.3× (March 2020) to 2.5× (April 2015); the current reading is higher than 96% of that period. That is below the Diagnostics & Research industry median of 5.7× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.9× | 2.31% |
| FY2024 | 1.9× | (9.23%) |
| FY2023 | 2.1× | 2.07% |
| FY2022 | 2.0× | (12.73%) |
| FY2021 | 2.3× | 48.23% |
| FY2020 | 1.6× | (11.79%) |
| FY2019 | 1.8× | 20.31% |
| FY2018 | 1.5× | (25.50%) |
| FY2017 | 2.0× | 15.94% |
| FY2016 | 1.7× | (6.17%) |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.1× | 4.84% |
| Mar 2026 | 2.0× | 3.76% |
| Dec 2025 | 1.9× | (11.06%) |
| Sep 2025 | 2.1× | 5.12% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICLR ICON PLC compare | 1.9× |
| LH Labcorp Holdings Inc. | 2.2× |
| DGX Quest Diagnostics Incorporated compare | 2.7× |
| CRL Charles River Laboratories International, Inc. compare | 4.1× |
| MEDP Medpace Holdings, Inc. compare | 6.1× |
| RVTY Revvity Inc. compare | 6.5× |
| MTD Mettler-Toledo International, Inc. compare | 7.9× |
| GH Guardant Health, Inc. compare | 20.3× |
| TWST Twist Bioscience Corporation compare | 26.2× |
| Diagnostics & Research industry median | 5.7× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement